0
USD
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Wet Macular Degeneration - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2019
Published Date: March 2019
|
Report Code: DELV-Apip-34
Home | Category |Health |Vision Care
Wet Macular Degeneration Global API Manufacturers Market  2019

Wet Macular Degeneration - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2019

Code: DELV-Apip-34
Report
March 2019
60 Pages
Delveinsight
Region: Global,
Description
Table of Content
Tables & Figures

Introduction
DelveInsight's, “Wet Macular Degeneration - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2019" report provides comprehensive insights about marketed and Phase III products for Wet Macular Degeneration . The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country.

Global API Manufacturers of Marketed Products for Wet Macular Degeneration
Coverage of API manufacturers for Wet Macular Degeneration marketed products spanning across United States, Europe, China and India. The manufacturers’ details include manufacturers’ name along with their location.

Emerging Phase III products for Wet Macular Degeneration
This report provides a comprehensive understanding of the emerging Phase III therapies for Wet Macular Degeneration which can turn out to be future prospective competitors for the marketed products. It will also put light on the current market trends. Their forecasted global sales are also provided till 2021.

Methodology
The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by DelveInsight team of industry experts.
Secondary information and data has been collected from various printable and non-printable sources like search engines, news websites, government websites, trade journals, white papers, magazines, trade associations, books, industry portals, industry associations and available databases.

Scope
• A review of the marketed products for Wet Macular Degeneration including their description, route of synthesis, regulatory milestones, forecasted sales estimates till 2021 and API manufacturer details.
• Patent information coverage of the marketed products including the patent number, holder, grant and patent expiry details
• API manufacturers for the marketed products with location details
• Emerging Phase III product profiles for Wet Macular Degeneration including product description, developmental activities, licensors & collaborators and chemical information

Reasons to Buy
• API intelligence for marketed drugs for the indication and gaining insights of API manufacturers
• Evaluate the marketing status and patent details of products to exploit opportunities for generic drug development
• Design effective counter-strategies to gain competitive advantage by identifying the key patent expiry details and exclusivity with respect to the indication
• Establish a comprehensive understanding of the emerging Phase III products which can be future competitors in this space

1. Report Introduction
2. Wet Macular Degeneration : Overview
• Risk Factors
• Causes
• Symptoms
• Pathophysiology
• Prognosis
• Diagnosis
• Treatment
3. Comparative Analysis of Marketed and Emerging Products
4. Marketed Therapies
4.1. Drug 1: Company name
• Product Description
• Route of Synthesis
• Mechanism of Action
• Pharmacology
• Pharmacodynamics
• Pharmacokinetics
• Adverse Reactions
• Clinical Trials
• Regulatory Milestones
• Product Development Activities
4.1.1 Product Details
• United States
• Europe
4.1.2 Global Sales Assessment
• Historical Global Sales
• Forecasted Global Sales
4.1.3 Patent Details
Other marketed products in the detailed report…..
5. Emerging Therapies (Phase III)
5.1 Drug Name : Company Name
• Product Description
• Research and Development
• Product Development Activities
5.1.1 Forecasted Global Sales
Other Phase III profiles in the detailed report…..
Appendix
Methodology
Consulting Services
About DelveInsight
Contact Us

List of Tables

Table 1: List of Marketed and Emerging Products
Table 2: Drug Product Details, United States
Table 3: Drug Product Details, Europe
Table 4: Drug, Historical Global Sales till 2018 (in million USD)
Table 5: Drug, Forecasted Global Sales from 2019-2021 (in million USD)
Table 6: API Manufacturers Region wise
Table 7: API Manufacturers for United States
Table 8: API Manufacturers for Europe
Table 9: API Manufacturers for China
Table 10: API Manufacturers for India
Table 11: Patent Details
Table 12: Emerging Therapies (Phase III)
Table 13: Drug, Forecasted Global Sales from 2019-2021 (in million USD)

List of Figures

Figure 1: Comparative Analysis of Marketed and Emerging Products
Figure 2: Drug, Historical Global Sales till 2018 (in million USD)
Figure 3: Drug, Forecasted Global Sales from 2019-2021 (in million USD)
Figure 4: Patent Details
Figure 5: API Manufacturers Region wise
Figure 6: Drug, Forecasted Global Sales from 2019-2021 (in million USD)

Introduction
DelveInsight's, “Wet Macular Degeneration - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2019" report provides comprehensive insights about marketed and Phase III products for Wet Macular Degeneration . The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country.

Global API Manufacturers of Marketed Products for Wet Macular Degeneration
Coverage of API manufacturers for Wet Macular Degeneration marketed products spanning across United States, Europe, China and India. The manufacturers’ details include manufacturers’ name along with their location.

Emerging Phase III products for Wet Macular Degeneration
This report provides a comprehensive understanding of the emerging Phase III therapies for Wet Macular Degeneration which can turn out to be future prospective competitors for the marketed products. It will also put light on the current market trends. Their forecasted global sales are also provided till 2021.

Methodology
The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by DelveInsight team of industry experts.
Secondary information and data has been collected from various printable and non-printable sources like search engines, news websites, government websites, trade journals, white papers, magazines, trade associations, books, industry portals, industry associations and available databases.

Scope
• A review of the marketed products for Wet Macular Degeneration including their description, route of synthesis, regulatory milestones, forecasted sales estimates till 2021 and API manufacturer details.
• Patent information coverage of the marketed products including the patent number, holder, grant and patent expiry details
• API manufacturers for the marketed products with location details
• Emerging Phase III product profiles for Wet Macular Degeneration including product description, developmental activities, licensors & collaborators and chemical information

Reasons to Buy
• API intelligence for marketed drugs for the indication and gaining insights of API manufacturers
• Evaluate the marketing status and patent details of products to exploit opportunities for generic drug development
• Design effective counter-strategies to gain competitive advantage by identifying the key patent expiry details and exclusivity with respect to the indication
• Establish a comprehensive understanding of the emerging Phase III products which can be future competitors in this space

Read More

1. Report Introduction
2. Wet Macular Degeneration : Overview
• Risk Factors
• Causes
• Symptoms
• Pathophysiology
• Prognosis
• Diagnosis
• Treatment
3. Comparative Analysis of Marketed and Emerging Products
4. Marketed Therapies
4.1. Drug 1: Company name
• Product Description
• Route of Synthesis
• Mechanism of Action
• Pharmacology
• Pharmacodynamics
• Pharmacokinetics
• Adverse Reactions
• Clinical Trials
• Regulatory Milestones
• Product Development Activities
4.1.1 Product Details
• United States
• Europe
4.1.2 Global Sales Assessment
• Historical Global Sales
• Forecasted Global Sales
4.1.3 Patent Details
Other marketed products in the detailed report…..
5. Emerging Therapies (Phase III)
5.1 Drug Name : Company Name
• Product Description
• Research and Development
• Product Development Activities
5.1.1 Forecasted Global Sales
Other Phase III profiles in the detailed report…..
Appendix
Methodology
Consulting Services
About DelveInsight
Contact Us

Read More

List of Tables

Table 1: List of Marketed and Emerging Products
Table 2: Drug Product Details, United States
Table 3: Drug Product Details, Europe
Table 4: Drug, Historical Global Sales till 2018 (in million USD)
Table 5: Drug, Forecasted Global Sales from 2019-2021 (in million USD)
Table 6: API Manufacturers Region wise
Table 7: API Manufacturers for United States
Table 8: API Manufacturers for Europe
Table 9: API Manufacturers for China
Table 10: API Manufacturers for India
Table 11: Patent Details
Table 12: Emerging Therapies (Phase III)
Table 13: Drug, Forecasted Global Sales from 2019-2021 (in million USD)

List of Figures

Figure 1: Comparative Analysis of Marketed and Emerging Products
Figure 2: Drug, Historical Global Sales till 2018 (in million USD)
Figure 3: Drug, Forecasted Global Sales from 2019-2021 (in million USD)
Figure 4: Patent Details
Figure 5: API Manufacturers Region wise
Figure 6: Drug, Forecasted Global Sales from 2019-2021 (in million USD)

Read More
SELECT A FORMAT
Added to Cart

Single User

Electronic (PDF)
$2000
This license allows only one user to access the PDF.

Site License

Electronic (PDF)
$4000
This license allows all the users of an enterprise residing in one location to access the PDF

Enterprise License

Electronic (PDF)
$6000
This license allows all the employees of an enterprise to access the PDF.
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Strategic Venue Partners

RELATED REPORTS

Global Optical Lens Edger Market Research Report 2021
Global Optical Lens Edger Market Research Report 2021

120 Pages
Type: Report
Code: QYRE-Auto-11N4403
Thu Feb 04 00:00:00 UTC 2021

Add to Cart

Global Polarized sunglasses Market Research Report 2021
Global Polarized sunglasses Market Research Report 2021

120 Pages
Type: Report
Code: QYRE-Auto-37H4167
Thu Feb 04 00:00:00 UTC 2021

Add to Cart

Global Anterior Uveitis Treatment Market Size Status and Forecast 2021 2027
Global Anterior Uveitis Treatment Market Size, Status and Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-11J4398
Thu Feb 04 00:00:00 UTC 2021

Add to Cart

Global Medical Protective Masks Market Research Report 2021
Global Medical Protective Masks Market Research Report 2021

120 Pages
Type: Report
Code: QYRE-Auto-37K4119
Mon Feb 01 00:00:00 UTC 2021

Add to Cart

0 Items
X
No items in the cart.
$0.0